Arteris director awarded 350 restricted shares

Munce Claudia F. reported acquisition or exercise transactions in this Form 4 filing.

Rhea-AI Filing Summary

Munce Claudia F. reported acquisition or exercise transactions in this Form 4 filing.

Arteris, Inc. director Claudia F. Munce received an award of 350 shares of common stock as fully vested restricted stock. According to the disclosure, this represents retainer fees she elected to take in stock instead of cash, valued using an average trading price of $39.28.

The grant was made on July 5, 2026 and brings her directly held position to 106,764 common shares. The filing also notes that she elected to defer the actual receipt of the shares, indicating this is structured as deferred equity compensation rather than an open-market purchase.

Insider Trade Summary

Grant/Award: 350 shares

Grant/Award 1 txn

Insider Munce Claudia F.

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	350	$0.00	$0.00

Holdings After Transaction: Common Stock — 106,764 shares (Direct)

Footnotes (2)

1. F1. Fully vested restricted stock. The restricted stock represents retainer fees that the Reporting Person elected to receive in the form of shares of common stock in lieu of cash. This grant of restricted stock was made on July 5, 2026, based on the average trading price of Arteris, Inc. common stock for the period from May 20, 2026 through July 2, 2026, which was $39.28.
2. F2. The Reporting Person elected to defer the receipt of shares.

Key Figures

Restricted stock grant: 350 shares Average pricing basis: $39.28 per share Shares after transaction: 106,764 shares +1 more

4 metrics

Restricted stock grant 350 shares Director retainer fees taken in stock on July 5, 2026

Average pricing basis $39.28 per share Average trading price from May 20, 2026 through July 2, 2026

Shares after transaction 106,764 shares Total Arteris common stock directly held after grant

Transaction price per share $0.00 No cash paid; equity grant classified as compensation

Key Terms

restricted stock, retainer fees, defer the receipt of shares, Grant, award, or other acquisition, +1 more

5 terms

restricted stock financial

"Fully vested restricted stock. The restricted stock represents retainer fees that the Reporting Person elected to receive"

Shares granted to an individual that carry limits on transfer or sale until certain conditions are met, such as staying with the company for a set time or hitting performance targets. Think of them as a locked gift that gradually opens; for investors they matter because they affect how many shares may enter the market later, signal management incentives and potential dilution, and reveal confidence in future company performance.

retainer fees financial

"represents retainer fees that the Reporting Person elected to receive in the form of shares of common stock"

defer the receipt of shares financial

"The Reporting Person elected to defer the receipt of shares."

Grant, award, or other acquisition financial

"transaction_code_description": "Grant, award, or other acquisition""

Common Stock financial

""security_title": "Common Stock""

Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.

FAQ

What insider transaction did Arteris (AIP) director Claudia Munce report?

Claudia F. Munce reported receiving 350 shares of Arteris common stock as fully vested restricted stock. The award represents board retainer fees she chose to take in shares instead of cash, structured as equity compensation rather than an open-market trade.

At what value were Claudia Munce’s Arteris (AIP) restricted shares determined?

The 350 restricted shares for Claudia Munce were based on an average Arteris common stock trading price of $39.28. This average covered the period from May 20, 2026 through July 2, 2026, as specified in the footnotes to the filing.

How many Arteris (AIP) shares does Claudia Munce hold after this Form 4?

Following the reported grant, Claudia Munce directly holds 106,764 shares of Arteris common stock. This figure includes the 350 fully vested restricted shares awarded as retainer fees, reflecting her updated direct ownership position disclosed in the Form 4.

Was Claudia Munce’s Arteris (AIP) Form 4 an open-market buy or sale?

The Form 4 reports a grant or award acquisition, not an open-market buy or sale. The 350 shares are fully vested restricted stock representing director retainer fees taken in stock, with no cash purchase price and no shares sold in this transaction.

Did Claudia Munce defer receipt of her Arteris (AIP) restricted shares?

Yes. A footnote states that Claudia Munce elected to defer the receipt of the shares. This means the grant is recorded as deferred equity compensation, even though the 350 restricted shares are fully vested and counted in her reported ownership total.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 07/07/2026 - 04:22 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Munce Claudia F.

(Last) (First) (Middle)

C/O ARTERIS, INC.

900 E. HAMILTON AVE., SUITE 300

(Street)

CAMPBELL CALIFORNIA 95008

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Arteris, Inc. [ AIP ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
07/05/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	07/05/2026		A		350(1)(2)	A	$0.00	106,764	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Fully vested restricted stock. The restricted stock represents retainer fees that the Reporting Person elected to receive in the form of shares of common stock in lieu of cash. This grant of restricted stock was made on July 5, 2026, based on the average trading price of Arteris, Inc. common stock for the period from May 20, 2026 through July 2, 2026, which was $39.28.

2. The Reporting Person elected to defer the receipt of shares.

Remarks:

	/s/ Paul Alpern, as Attorney-in-Fact for Munce Claudia F.	07/07/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)